Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST)

Eldrin F. Lewis(Brigham and Women's Hospital), Chun‐Lan Chang(Novartis (United States)), Theresa Coles(RTI Health Solutions), Carla DeMuro(RTI Health Solutions), Donald E. Stull(IQVIA (United States)), Stuart Turner(Novartis (United States)), Amy Barrett(Churchill Hospital), Lauren Nelson(RTI Health Solutions), Sandy Lewis(RTI Health Solutions)
Journal of Patient-Reported Outcomes
May 2, 2019
10.1186/s41687-019-0113-6
Cited by 15

Related Papers

Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
|Circulation|2014|1k